This is true and it will help ELN cut their debt significantly, and help them to speed up the Alzheimer drug research. However the biggest winner if and when this drug comes on the market will be WYE and ultimately PFE since they are acquiring WYE. ELN has extensive collaboration with WYE, and they will receive 50% of drug's profit with ELN getting slightly under 25% and JNJ getting slightly more than 25%. This is again a win win situation for PFE and bloody wall Street doesnt seem to recognize any thing good that might happen to PFE and WYE. But they will eventually when the reality sets in.